W. Lawrence Drew

4.4k total citations
65 papers, 3.1k citations indexed

About

W. Lawrence Drew is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, W. Lawrence Drew has authored 65 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 11 papers in Infectious Diseases and 7 papers in Virology. Recurrent topics in W. Lawrence Drew's work include Cytomegalovirus and herpesvirus research (46 papers), Herpesvirus Infections and Treatments (26 papers) and Ocular Diseases and Behçet’s Syndrome (7 papers). W. Lawrence Drew is often cited by papers focused on Cytomegalovirus and herpesvirus research (46 papers), Herpesvirus Infections and Treatments (26 papers) and Ocular Diseases and Behçet’s Syndrome (7 papers). W. Lawrence Drew collaborates with scholars based in United States, United Kingdom and Myanmar. W. Lawrence Drew's co-authors include Richard C. Miner, Lawrence Mintz, Mark F. Sands, Theodore N. Finley, David W. Golde, Sunwen Chou, Edward S. Mocarski, Jacob Lalezari, John D. Roback and Kenrad E. Nelson and has published in prestigious journals such as The Lancet, JAMA and Annals of Internal Medicine.

In The Last Decade

W. Lawrence Drew

63 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Lawrence Drew United States 31 2.3k 719 563 455 403 65 3.1k
Abe M. Macher United States 28 1.8k 0.8× 1.1k 1.5× 809 1.4× 315 0.7× 708 1.8× 86 3.4k
Corinne Liesnard Belgium 26 1.3k 0.6× 864 1.2× 304 0.5× 233 0.5× 713 1.8× 75 2.3k
J D Meyers United States 20 2.6k 1.1× 711 1.0× 151 0.3× 853 1.9× 480 1.2× 28 3.2k
Dominique Salmon‐Céron France 35 2.2k 0.9× 2.0k 2.8× 931 1.7× 497 1.1× 430 1.1× 161 4.8k
Karina Butler Ireland 29 975 0.4× 1.4k 1.9× 657 1.2× 216 0.5× 187 0.5× 108 2.6k
Howard M. Schanker United States 7 850 0.4× 703 1.0× 711 1.3× 224 0.5× 680 1.7× 14 2.2k
A J Pinching United Kingdom 30 907 0.4× 709 1.0× 422 0.7× 184 0.4× 613 1.5× 59 3.0k
C. Michelet France 29 1.1k 0.5× 1.1k 1.5× 494 0.9× 149 0.3× 201 0.5× 94 2.5k
Barbara G. Werner United States 33 2.6k 1.1× 1.0k 1.4× 172 0.3× 448 1.0× 322 0.8× 70 3.5k
Michael Kidd United Kingdom 32 1.5k 0.7× 1.9k 2.6× 152 0.3× 474 1.0× 669 1.7× 65 3.7k

Countries citing papers authored by W. Lawrence Drew

Since Specialization
Citations

This map shows the geographic impact of W. Lawrence Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Lawrence Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Lawrence Drew more than expected).

Fields of papers citing papers by W. Lawrence Drew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Lawrence Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Lawrence Drew. The network helps show where W. Lawrence Drew may publish in the future.

Co-authorship network of co-authors of W. Lawrence Drew

This figure shows the co-authorship network connecting the top 25 collaborators of W. Lawrence Drew. A scholar is included among the top collaborators of W. Lawrence Drew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Lawrence Drew. W. Lawrence Drew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heiden, David, Frank Smithuis, Jeremy D. Keenan, et al.. (2018). Active cytomegalovirus retinitis after the start of antiretroviral therapy. British Journal of Ophthalmology. 103(2). 157–160. 12 indexed citations
2.
London, Nikolas, Moe Kyaw Kyaw, Frank Smithuis, et al.. (2011). CMV retinitis screening and treatment in a resource‐poor setting: three‐year experience from a primary care HIV/AIDS programme in Myanmar. Journal of the International AIDS Society. 14(1). 41–41. 25 indexed citations
3.
Liu, Catherine, Brian S. Schwartz, Snigdha Vallabhaneni, et al.. (2010). Pandemic (H1N1) 2009 Infection in Patients with Hematologic Malignancy. Emerging infectious diseases. 16(12). 1910–1917. 14 indexed citations
4.
Drew, W. Lawrence. (2007). Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Current Opinion in Infectious Diseases. 20(4). 408–411. 65 indexed citations
5.
Roback, John D., Maureen G. Conlan, W. Lawrence Drew, et al.. (2005). The Role of Photochemical Treatment With Amotosalen and UV-A Light in the Prevention of Transfusion-Transmitted Cytomegalovirus Infections. Transfusion Medicine Reviews. 20(1). 45–56. 24 indexed citations
6.
Imai, Yumi, et al.. (2004). Emergence of Drug‐Resistant Cytomegalovirus Retinitis in the Contralateral Eyes of Patients with AIDS Treated with Ganciclovir. The Journal of Infectious Diseases. 189(4). 611–615. 11 indexed citations
7.
Drew, W. Lawrence, Sunwen Chou, Beth A. Mohr, et al.. (2003). Absence of activation of CMV by blood transfusion to HIV‐infected, CMV‐seropositive patients. Transfusion. 43(10). 1351–1357. 6 indexed citations
8.
Chou, Sunwen, Rachel H. Waldemer, Kevin S. Michels, et al.. (2002). Cytomegalovirus UL97 Phosphotransferase Mutations That Affect Susceptibility to Ganciclovir. The Journal of Infectious Diseases. 185(2). 162–169. 147 indexed citations
9.
Roback, John D., Christopher D. Hillyer, W. Lawrence Drew, et al.. (2001). Multicenter evaluation of PCR methods fordetecting CMV DNA in blood donors. Transfusion. 41(10). 1249–1257. 43 indexed citations
10.
Para, Michael F., Leslie A. Kalish, Ann C. Collier, et al.. (2001). Qualitative and Quantitative PCR Measures of Cytomegalovirus in Patients With Advanced HIV Infection Who Require Transfusions. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(4). 320–325. 1 indexed citations
11.
Chou, Sunwen, Richard C. Miner, & W. Lawrence Drew. (2000). A Deletion Mutation in Region V of the Cytomegalovirus DNA Polymerase Sequence Confers Multidrug Resistance. The Journal of Infectious Diseases. 182(6). 1765–1768. 44 indexed citations
12.
Drew, W. Lawrence, et al.. (1999). Decrease of Cytomegalovirus Replication in Human Immunodeficiency Virus Infected–Patients after Treatment with Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 180(3). 847–849. 62 indexed citations
13.
Chou, Sunwen, Gail I. Marousek, Stephen Follansbee, et al.. (1997). Evolution of Mutations Conferring Multidrug Resistance during Prophylaxis and Therapy for Cytomegalovirus Disease. The Journal of Infectious Diseases. 176(3). 786–789. 135 indexed citations
14.
Meer, Jan T. M. van der, W. Lawrence Drew, Raleigh A. Bowden, et al.. (1996). Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection. Antiviral Research. 32(3). 119–140. 73 indexed citations
15.
Spector, Stephen A., David F. Busch, Stephen Follansbee, et al.. (1995). Pharmacokinetic, Safety, and Antiviral Profiles of Oral Ganciclovir in Persons Infected with Human Immunodeficiency Virus: A Phase I/II Study. The Journal of Infectious Diseases. 171(6). 1431–1437. 85 indexed citations
16.
Drew, W. Lawrence, et al.. (1993). Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals. Clinical and Diagnostic Virology. 1(3). 179–185. 62 indexed citations
17.
Drew, W. Lawrence, et al.. (1990). Evaluation of the Virus Permeability of a New Condom for Women. Sexually Transmitted Diseases. 17(2). 110–112. 77 indexed citations
18.
Drew, W. Lawrence. (1988). Diagnosis of Cytomegalovirus Infection. Clinical Infectious Diseases. 10(Supplement_3). S468–S476. 122 indexed citations
19.
Palmer, P. E. S., Theodore N. Finley, W. Lawrence Drew, & David W. Golde. (1978). Radiographic aspects of occult pulmonary haemorrhage. Clinical Radiology. 29(2). 139–143. 6 indexed citations
20.
Golde, David W., W. Lawrence Drew, Henry Klein, Theodore N. Finley, & Martin J. Cline. (1975). Occult pulmonary haemorrhage in leukaemia.. BMJ. 2(5964). 166–168. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abe M. Macher Breakdown of academic impact, for papers by Corinne Liesnard Breakdown of academic impact, for papers by J D Meyers Breakdown of academic impact, for papers by Dominique Salmon‐Céron Breakdown of academic impact, for papers by Karina Butler Breakdown of academic impact, for papers by Howard M. Schanker Breakdown of academic impact, for papers by A J Pinching Breakdown of academic impact, for papers by C. Michelet Breakdown of academic impact, for papers by Barbara G. Werner Breakdown of academic impact, for papers by Michael Kidd
Rankless by CCL
2026